Correction: The effect of dapagliflozin on cardiorespiratory fitness in patients with coronary heart disease and type 2 diabetes mellitus following PCI: a single-center prospective randomized controlled study - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: Impact of Dapagliflozin on Cardiorespiratory Fitness in Individuals with Coronary Heart Disease and Type 2 Diabetes Mellitus Post-PCI: A Prospective Randomized Controlled Trial at a Single Center

  • By

  • Jiali Yang

  • Xinru Li

  • Liangqiu Tang

  • Wenmao Fan

  • Aihua Li

  • Wanming Zhou

  • Jungang Pang

  • Qiuxiao Yuan

  • Ming Zhong

  • Jinhui Hou

  • Lan Wang

  • Wenjiao Liao

  • Xiangyang Liu

  • BMC Cardiovascular

  • June 2, 2026

Share

Objective:

To correct inaccuracies in the data presented in the original article regarding the impact of Dapagliflozin, specifically detailing the nature of the inaccuracies.

Approach:
    Key Findings:
    • ACEI medication proportion in the Dapagliflozin group corrected from '8(10.03)' to '8(14.03)'
    • Nitrates proportion in the Non-dapagliflozin group corrected from '38(67.86)' to '27(48.21)'
    • BMI P-value corrected from '0.720' to '0.072'
    • Entries in Table 6 for Adjusted OR, 95% CI, and P were also corrected.
    Interpretation:

    Conclusion:

    Sources:

Original Source(s)

Correction: The effect of dapagliflozin on cardiorespiratory fitness in patients with coronary heart disease and type 2 diabetes mellitus following PCI: a single-center prospective randomized controlled study

  • by Jiali Yang, Xinru Li, Liangqiu Tang, Wenmao Fan, Aihua Li, Wanming Zhou, Jungang Pang, Qiuxiao Yuan, Ming Zhong, Jinhui Hou, Lan Wang, Wenjiao Liao, Xiangyang Liu, BMC Cardiovascular

  • June 2, 2026

Related Content

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

Consensus Panel Calls for Enhanced Radiation Shielding

A consensus statement called for immediate adoption of enhanced radiation protection devices, although evidence of long-term health benefits and effectiveness across procedural settings remains limited.

Female patients less likely to receive invasive care

Review identifies recurring sex-based differences across specialties, including lower use of intensive and guideline-compliant treatment among female patients.